Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

19 Oct 2021

Abstract excerpt

Liver disease, particularly viral hepatitis and hepatocellular carcinoma (HCC), is a global healthcare burden and leads to more than 2 million deaths per year worldwide. Despite some success in diagnosis and vaccine development, there are still unmet needs to improve diagnostics and therapeutics for viral hepatitis and HCC. The emerging clustered regularly interspaced short palindromic repeat/associated proteins...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Innovation and Socioeconomic Development
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34665528
DOI: 10.1002/advs.202102051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular CarcinomaPMID 34665528Read ↗

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinomaSemantic proximity Read ↗

Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infectionSemantic proximity Read ↗

Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatmentSemantic proximity Read ↗

CRISPR/Cas9 for hepatitis B virus infection treatmentSemantic proximity Read ↗

CRISPR/Cas9 therapeutics for liver diseases.Semantic proximity Read ↗

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular CarcinomaSemantic proximity Read ↗

CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical BarriersSemantic proximity Read ↗

Tackling hepatitis B Virus with CRISPR/Cas9: advances, challenges, and delivery strategiesSemantic proximity Read ↗

Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited DiseasesSemantic proximity Read ↗

CRISPR/Cas9: at the cutting edge of hepatology.Semantic proximity Read ↗

CRISPR Editing in Biological and Biomedical Investigation.Semantic proximity Read ↗

Advancements in CRISPR/Cas systems for disease treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.